Trials
Search / Trial NCT05651906

The Role of Endothelial Glycocalyx in Kidney Transplantation

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Dec 13, 2022

Trial Information

Current as of January 13, 2025

Recruiting

Keywords

Endothelial Glycocalyx

ClinConnect Summary

This clinical trial is studying a part of the blood vessel lining called the endothelial glycocalyx (EG) and its role in kidney transplantation. Researchers want to learn more about how EG breaks down before and after a kidney transplant by checking blood and urine samples from both the kidney donors and the recipients. They will also use a special imaging technique to visualize the EG directly. The goal is to better understand how EG affects kidney transplants and why it is important.

To participate in this study, you need to be someone who is undergoing a kidney transplant. The trial is open to all genders, and the only requirement is that you must agree to participate by signing an informed consent form. If you join the study, you can expect to have your blood and urine tested, and you may undergo some imaging procedures to help researchers gather important information. This study is currently recruiting participants, so if you or someone you know is considering a kidney transplant, this could be an opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing kidney transplantation
  • Exclusion Criteria:
  • Patients who don't sign the informed consent

About Charles University, Czech Republic

Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.

Locations

Hradec Králové, Czech Republic, Czechia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials